Performance Evaluation of the LumiraDx SARS-CoV-2 & FLU A/B and SARS-CoV-2 & RSV Tests for Aid in the Assessment of COVID-19
type: MedicalStudy
description: A Multicenter Study Conducted to Evaluate the Performance of the LumiraDx SARS-CoV-2 & FLU A/B Test, and LumiraDx SARS-CoV-2 & RSV Test at Point of Care Testing Sites
status: COMPLETED
study design: INTERVENTIONAL
phase: NA
start date: 2022-01-04
end date: 2023-03-14
license: https://creativecommons.org/publicdomain/zero/1.0/
source: https://clinicaltrials.gov/study/NCT05268939
source organization: US National Library of Medicine
publisher: AI Analytics
sponsor: LumiraDx UK Limited
study subject: COVID-19
study subject: Influenza A
study subject: Influenza Type B
study subject: RSV Infection
keywords: NA
keywords: INTERVENTIONAL
keywords: COMPLETED
keywords: COVID-19
keywords: Influenza A
keywords: Influenza Type B
keywords: RSV Infection

AI Analytics
type: Organization